Diagonal Pharma develops a viral detection platform,
bringing unprecedented speed and ease to diagnostics.
Andreas is an accomplished scientist with expertise spanning inflammation, immunity and cancer biology. He spent four years at the medtech startup Immunovia in Lund, Sweden where he was instrumental in the development of a diagnostic test for early stage pancreatic cancer.
Johan has co-founded several companies within biotech and has acquired extensive knowledge in medtech product development, IP, strategy and finance. He has successfully commercialized multiple innovations and has considerable experience from both IPO and industry sales.
Kush is an innovator, project manager and tech-matchmaker in the fields of medical technology and diagnostics. After his graduate studies in microfluidics and biosensors, Kush has co-founded several tech startups besides his key role as the CEO at the male fertility startup Spermosens AB,
A researcher of prominence in the field of genomics, Vicent is currently paving the way for rapid viral diagnostic testing during the 2020 COVID-19 pandemic. He obtained a PhD in biochemistry at the University of Valencia, Spain. He next joined the Genome Biology Unit at EMBL Heidelberg, Germany, and was appointed Staff Scientist there in 2012, exploring mRNA metabolism. Vicent was recently appointed Associate Professor at the Karolinska Institute and is a SciLifeLab and Wallenberg Academy Fellow.
Recipient of the prestigious European Research Council's 2015 Consolidator Grant, Christelle is an interdisplinary scientist at NanoLund. Physicist by training, her applied research in biology exploits cutting edge techniques including super resolution microscopy, metalorganic vapor phase epitaxy,
flow cytometry, focusing on nanowire based sensors for mechnosensing and biosensing, and nano-tools for cargo delivery in living cells. She is also active in the areas of toxicology of nanomaterials.
A renowned scientist in analytical chemistry, Taut is an expert in electrochemistry, impedance spectroscopy and biosensors. He also serves as the
Research Coordinator of several projects at Dept of Biomedical Sciences, Malmö University. Besides his active involvement in R&D of industrial significance, his research also focuses on development of RFID sensors for non-invasive sensing, monitoring of drug delivery, and woundcare, and has been working on creating in-vitro models of inflammation.
If you would like to test our technology with your laboratory or clinical samples, we are just a message away!